{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:18:39Z","timestamp":1790216319454,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.autrev.2026.104037","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T15:58:12Z","timestamp":1774108692000},"page":"104037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Isolated antineutrophil cytoplasmic antibody\u2013associated interstitial lung disease: A systematic review of an emerging condition"],"prefix":"10.1016","volume":"25","author":[{"given":"Javier","family":"Narv\u00e1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pol","family":"Maym\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2026.104037_bb0005","article-title":"ANCA-associated vasculitis and interstitial lung disease: challenges and open questions","author":"Prieto-Gonz\u00e1lez","year":"2025","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0010","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/art.41983","article-title":"2022 American college of rheumatology\/European alliance of associations for rheumatology classification criteria for microscopic polyangiitis","volume":"74","author":"Suppiah","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104037_bb0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.autrev.2017.05.008","article-title":"Interstital lung disease in ANCA vasculitis","volume":"16","author":"Alba","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104037_bb0020","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.rmed.2013.01.006","article-title":"Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis","volume":"107","author":"Ando","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2014-000058","article-title":"Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis","volume":"2","author":"Kagiyama","year":"2015","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.autrev.2026.104037_bb0030","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0123-2021","article-title":"Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.autrev.2026.104037_bb0035","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MCP.0000000000001187","article-title":"ANCA associated pulmonary fibrosis: vasculitis or not vasculitis","volume":"31","author":"Codes-M\u00e9ndez","year":"2025","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0040","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14010229","article-title":"Clinical profiles, survival, and lung function outcomes in ANCA-associated interstitial lung disease: an observational study","volume":"14","author":"Valero-Mart\u00ednez","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.resinv.2024.11.006","article-title":"Clinical characteristics and prognostic factors for MPO-ANCA positive interstitial lung disease: a comparative study of ANCA associated vasculitis (AAV)-ILD and pulmonary limited vasculitis","volume":"63","author":"Shimamura","year":"2025","journal-title":"Respir Investig"},{"key":"10.1016\/j.autrev.2026.104037_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.70271","article-title":"Myeloperoxidase-antibody positivity and progression to microscopic polyangiitis in interstitial lung disease: a case series","volume":"13","author":"Hoskins","year":"2025","journal-title":"Respirol Case Rep"},{"key":"10.1016\/j.autrev.2026.104037_bb0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12890-025-03736-4","article-title":"Clinical significance of anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonia: a retrospective observational study","volume":"25","author":"Sun","year":"2025","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/eci.70025","article-title":"Anti-neutrophil cytoplasmic antibodies associated interstitial pneumonia: a possible new clinical entity","volume":"55","author":"Iannone","year":"2025","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.autrev.2026.104037_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/crj.70061","article-title":"Differences in radiological and pathological findings by ANCA-subtype in ANCA-positive idiopathic interstitial pneumonias","volume":"19","author":"Sawata","year":"2025","journal-title":"Clin Respir J"},{"key":"10.1016\/j.autrev.2026.104037_bb0075","article-title":"Interstitial lung diseases associated with ANCA positivity: a different disease spectrum from interstitial pneumonia with autoimmune features","volume":"86","author":"Zhu","year":"2024","journal-title":"Respir Med Res"},{"key":"10.1016\/j.autrev.2026.104037_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152484","article-title":"Progression to ANCA-associated vasculitis in patients with idiopathic interstitial pneumonia and positive ANCA","volume":"68","author":"Lee","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104037_bb0085","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/acr2.11679","article-title":"Comparison of interstitial lung disease between antineutrophil cytoplasmic antibodies positive and negative patients: a retrospective cohort study","volume":"6","author":"Shen","year":"2024","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.autrev.2026.104037_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2024.100235","article-title":"Presentation and progression of MPO-ANCA interstitial lung disease","volume":"8","author":"Salvati","year":"2024","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.autrev.2026.104037_bb0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10067-022-06388-5","article-title":"Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease","volume":"42","author":"Yamaguchi","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2026.104037_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45027-0","article-title":"Outcomes and prognosis of progressive pulmonary fibrosis in patients with antineutrophil cytoplasmic antibody-positive interstitial lung disease","volume":"13","author":"Sakamoto","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2026.104037_bb0105","article-title":"Clinical and prognostic significance of p-ANCA positivity in idiopathic pulmonary fibrosis: a retrospective observational study","volume":"13","author":"Libra","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.autrev.2026.104037_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106992","article-title":"Acute exacerbation in antineutrophil cytoplasmic antibody-associated interstitial lung disease: clinical features and risk factors","volume":"203","author":"Otsuka","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10122548","article-title":"Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association","volume":"10","author":"Sebastiani","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199659","article-title":"Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias","volume":"13","author":"Hozumi","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2026.104037_bb0125","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/resp.12763","article-title":"Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis","volume":"21","author":"Hosoda","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.autrev.2026.104037_bb0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00408-016-9851-x","article-title":"Clinical implication of proteinase-3-antineutrophil cytoplasmic antibody in patients with idiopathic interstitial pneumonias","volume":"194","author":"Hozumi","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.autrev.2026.104037_bb0135","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.rmed.2012.08.024","article-title":"Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients","volume":"106","author":"Tanaka","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000183754","article-title":"A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients","volume":"77","author":"Nozu","year":"2009","journal-title":"Respiration"},{"key":"10.1016\/j.autrev.2026.104037_bb0145","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.rmed.2008.04.023","article-title":"ANCA-associated lung fibrosis: analysis of 17 patients","volume":"102","author":"Foulon","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-1843.2004.00581.x","article-title":"Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides","volume":"9","author":"Homma","year":"2004","journal-title":"Respirology"},{"key":"10.1016\/j.autrev.2026.104037_bb0155","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ckj\/sfaa139","article-title":"Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome","volume":"14","author":"Trivioli","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2026.104037_bb0160","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MD.0000000000000217","article-title":"Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature","volume":"93","author":"Comarmond","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2026.104037_bb0165","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/ajrccm.160.3.9807139","article-title":"Antimyeloperoxidase-associated lung disease. An experimental model","volume":"160","author":"Foucher","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0170","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1183\/09031936.00148409","article-title":"The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis","volume":"37","author":"Guilpain","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2026.104037_bb0175","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0180","doi-asserted-by":"crossref","first-page":"E9618","DOI":"10.1073\/pnas.1708247114","article-title":"Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis","volume":"114","author":"Schreiber","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2026.104037_bb0185","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nrrheum.2017.189","article-title":"Vasculitis syndromes: NET production complements endothelial damage","volume":"13","author":"Collison","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104037_bb0190","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/annrheumdis-2018-214263","article-title":"Association of MUC5B promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis","volume":"78","author":"Namba","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104037_bb0195","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s13075-020-02347-0","article-title":"Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population: a genetic association study","volume":"22","author":"Kawasaki","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2026.104037_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102660","article-title":"Environmental risk factors associated with ANCA associated vasculitis: a systematic mapping review","volume":"19","author":"Scott","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104037_bb0205","article-title":"Environmental factors influencing the risk of ANCA-associated vasculitis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104037_bb0210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1034\/j.1399-3003.1999.14a20.x","article-title":"Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activity","volume":"14","author":"Schnabel","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2026.104037_bb0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00000478-199104000-00001","article-title":"Surgical pathology of the lung in Wegener\u2019s granulomatosis. Review of 87 open lung biopsies from 67 patients","volume":"15","author":"Travis","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.autrev.2026.104037_bb0220","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccm.2019.05.012","article-title":"Update on the management of respiratory manifestations of the antineutrophil cytoplasmic antibodies-associated vasculitides","volume":"40","author":"Thompson","year":"2019","journal-title":"Clin Chest Med"},{"issue":"Supplement_1","key":"10.1016\/j.autrev.2026.104037_bb0225","doi-asserted-by":"crossref","first-page":"i42","DOI":"10.1093\/rheumatology\/keae557","article-title":"Interstitial lung disease, antineutrophil cystoplasmic antibodies and microscopic polyangiitis","volume":"64","author":"Specks","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104037_bb0230","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MCP.0000000000000979","article-title":"Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment","volume":"29","author":"Turgeon","year":"2023","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.autrev.2026.104037_bb0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104037_bb0240","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American college of rheumatology\/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226000510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226000510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T14:28:29Z","timestamp":1775053709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226000510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1568997226000510"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104037","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolated antineutrophil cytoplasmic antibody\u2013associated interstitial lung disease: A systematic review of an emerging condition","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104037"}}